Related references
Note: Only part of the references are listed.24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations
Sandeep Thakkar et al.
CNS DRUGS (2021)
Concomitant Medication Usage with Levodopa-Carbidopa Intestinal Gel: Results from the COSMOS Study
Alfonso Fasano et al.
MOVEMENT DISORDERS (2021)
PROSPECTIVE STUDY OF 24-HOUR LEVODOPACARBIDOPA INTESTINAL GEL THERAPY FOR UNRESPONSIVE FREEZING OF GAIT
Sai Nagaratnam et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication
Igor Straka et al.
FRONTIERS IN NEUROLOGY (2019)
Gastric emptying in Parkinson's disease - A mini-review
Karoline Knudsen et al.
PARKINSONISM & RELATED DISORDERS (2018)
24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson's disease
Belinda Cruse et al.
NPJ PARKINSONS DISEASE (2018)
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease
David G. Standaert et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
The clinical symptoms of Parkinson's disease
Sigurlaug Sveinbjornsdottir
JOURNAL OF NEUROCHEMISTRY (2016)
24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease
Lucia Ricciardi et al.
MOVEMENT DISORDERS (2016)
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
Angelo Antonini et al.
MOVEMENT DISORDERS (2016)
24 h Levodopa-carbidopa intestinal gel may reduce falls and unresponsive freezing of gait in Parkinson's disease
Florence C. F. Chang et al.
PARKINSONISM & RELATED DISORDERS (2015)
Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets
Ahmed A. Othman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
for the LCIG Horizon Study Group. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (vol 13, pg 141, 2014)
C. W. Olen et al.
LANCET NEUROLOGY (2014)
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
C. Warren Olanow et al.
LANCET NEUROLOGY (2014)
Levodopa: Past, Present, and Future
Robert A. Hauser
EUROPEAN NEUROLOGY (2009)
Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
O.K. Sujith et al.
Therapeutic Advances in Neurological Disorders (2009)
Levodopa for the Treatment of Parkinson's Disease.
Peter A. LeWitt
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease
D Nyholm et al.
NEUROLOGY (2005)
Optimizing levodopa phannacokinetics:: Intestinal infusion versus oral sustained-release tablets
D Nyholm et al.
CLINICAL NEUROPHARMACOLOGY (2003)
Share Paper
